Summary by Moomoo AI
Arcutis Biotherapeutics, Inc. officer Matsuda Masaru is set to sell 3,760 shares of common stock on March 4, 2024, with an aggregate market value of $41,815. The shares were acquired on March 1, 2024, through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a period where no previous sales were reported in the past three months.